To comply with Canadian International Pharmacy Association regulations you are permitted to order a 3-month supply or the closest package size available based on your personal prescription. read more
(rem de' si vir)Remdesivir is an antiviral medication currently being studied for the treatment of coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus. Only limited clinical trial information is available at this time to support the use of remdesivir for the treatment of COVID-19. Some initial studies indicate that certain people in the hospital who have COVID-19 may benefit from receiving remdesivir because it may shorten the time to recovery. However, more information is needed to know how well remdesivir works for the treatment of COVID-19. More information is also needed about the possible adverse events that may occur from receiving remdesivir. There are currently no FDA-approved products available to treat COVID-19. Remdesivir has not undergone the standard review to be approved by the FDA for use. However, the FDA has approved an Emergency Use Authorization (EUA) to allow adults and children who are hospitalized with severe COVID-19 to receive remdesivir. Talk to your doctor about the risks and benefits of receiving this medication.